Fitness to Drive After Syncope and/or in Cardiovascular Disease – An Overview and Practical Advice

Norman, 1958, The health of bus drivers: a study in London transport, Lancet, 2, 807, 10.1016/S0140-6736(58)90373-8 Halinen, 1994, Fatal road accidents caused by sudden death of the driver in Finland and Vaud, Switzerland, Eur Heart J, 15, 888, 10.1093/oxfordjournals.eurheartj.a060606 Syncope, 2000, New Engl J Med, 343, 1856, 10.1056/NEJM200012213432507 Brignole, 2018, 2018 ESC Guidelines for the diagnosis and management of syncope, Eur Heart J, 39, 1883, 10.1093/eurheartj/ehy037 Savage, 1985, Epidemiologic features of isolated syncope: the Framingham Study, Stroke J Cereb Circul, 16, 626, 10.1161/01.STR.16.4.626 Soteriades, 2002, Incidence and prognosis of syncope, New Engl J Med, 347, 878, 10.1056/NEJMoa012407 Morichetti, 1998, [Epidemiological and clinical findings in 697 syncope events], Minerva Med, 89, 211 Buttner, 1999, Sudden natural death 'at the wheel': a retrospective study over a 15-year time period (1982-1996), Forensic Sci Int, 103, 101, 10.1016/S0379-0738(99)00063-8 Hitosugi, 2012, Sudden illness while driving a vehicle–a retrospective analysis of commercial drivers in Japan, Scand J Work Environ Health, 38, 84, 10.5271/sjweh.3189 Tervo, 2008, Observational failures/distraction and disease attack/incapacity as cause(s) of fatal road crashes in Finland, Traffic Inj Prev, 9, 211, 10.1080/15389580802040303 Oliva, 2011, Autopsy investigation and Bayesian approach to coronary artery disease in victims of motor-vehicle accidents, Atherosclerosis, 218, 28, 10.1016/j.atherosclerosis.2011.05.012 Pezawas, 2017, Risk of arrhythmic death in ischemic heart disease: a prospective, controlled, observer-blind risk stratification over 10 years, Eur J Clin Invest, 47, 231, 10.1111/eci.12729 Pezawas, 2008, Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease, Heart, 94, e17, 10.1136/hrt.2007.116616 Epstein, 2007, Circulation, 115, 1170, 10.1161/CIRCULATIONAHA.106.180203 Task Force for the, 2009, Guidelines for the diagnosis and management of syncope (version 2009), Eur Heart J, 30, 2631, 10.1093/eurheartj/ehp298 Bundesministerium für Verkehr IuT. Leitlinien für die gesundheitliche Eignung von Kraftfahrzeuglenkern. 2019. p. 1-253. Simpson, 2004, Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary, Can J Cardiol, 20, 1314 Curtis AB, Epstein AE. Syncope while driving: how safe is safe? Circulation. 2009;120:921-3. Larsen, 1994, Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia. Implications for driving restrictions, JAMA, 271, 1335, 10.1001/jama.1994.03510410047031 Parsons, 1986, Fits and other causes of loss of consciousness while driving, Q J Med, 58, 295 Ostrom, 1987, Natural death while driving, J Forensic Sci, 32, 988, 10.1520/JFS12410J Vijgen, 2010, Consensus statement of the European Heart Rhythm Association: updated recommendations for driving by patients with implantable cardioverter defibrillators, Eur J Cardiovasc Nurs, 9, 3, 10.1016/j.ejcnurse.2010.01.001 Fox, 2008, Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry, Nat Clin Pract Cardiovasc Med, 5, 580, 10.1038/ncpcardio1302 Hess, 2016, Sudden cardiac death after non-ST-segment elevation acute coronary syndrome, JAMA Cardiol, 1, 73, 10.1001/jamacardio.2015.0359 Freedberg, 2001, Recurrence of symptomatic ventricular arrhythmias in patients with implantable cardioverter defibrillator after the first device therapy: implications for antiarrhythmic therapy and driving restrictions. CARE Group, J Am Coll Cardiol., 37, 1910, 10.1016/S0735-1097(01)01226-8 Whang, 2004, Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study, Circulation, 109, 1386, 10.1161/01.CIR.0000120703.99433.1E Pezawas, 2014, Multiple autonomic and repolarization investigation of sudden cardiac death in dilated cardiomyopathy and controls, Circul Arrhythm Electrophysiol, 7, 1101, 10.1161/CIRCEP.114.001745 Pezawas, 2020, Importance of diastolic function for the prediction of arrhythmic death: a prospective, observer-blinded, long-term study, Circul Arrhythm Electrophysiol, 13, 10.1161/CIRCEP.119.007757 Pezawas, 2003, Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy, Europace, 5, 305, 10.1016/S1099-5129(03)00044-8 Findling, 2020, Cardiac autonomic dysfunction in multiple sclerosis: a systematic review of current knowledge and impact of immunotherapies, J Clin Med, 9, 10.3390/jcm9020335 Sorajja, 2009, Syncope while driving: clinical characteristics, causes, and prognosis, Circulation, 120, 928, 10.1161/CIRCULATIONAHA.108.827626 Nume, 2016, Syncope and motor vehicle crash risk: a Danish Nationwide study, JAMA Intern Med, 176, 503, 10.1001/jamainternmed.2015.8606 Burger, 2018, Defensive implantable cardioverter-defibrillator programming is safe and reduces inappropriate therapy- comparison of 3 programming strategies in 1,471 patients, Circul J, 82, 2976, 10.1253/circj.CJ-18-0611 Burger, 2020, Appropriate and inappropriate therapy in patients with single- or multi-chamber implantable cardioverter-defibrillators, Hellenic J Cardiol, 10.1016/j.hjc.2020.03.001 Burger, 2019, Sex difference in inappropriate therapy and survival among 1471 implantable cardioverter-defibrillator recipients, J Cardiovasc Electrophysiol, 30, 1620, 10.1111/jce.14003 Margulescu, 2019, A review of driving restrictions in patients at risk of syncope and cardiac arrhythmias associated with sudden incapacity: differing global approaches to regulation and risk, Arrhythm Electrophysiol Rev, 8, 90, 10.15420/aer.2019.13.2 Watanabe, 2017, Driving restrictions in patients with implantable cardioverter defibrillators and pacemakers, J Arrhythm, 33, 594, 10.1016/j.joa.2017.02.003 Shen, 2017, 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society, J Am Coll Cardiol, 70, 620, 10.1016/j.jacc.2017.03.002 Klein, 2018, [Syncope and fitness to drive], Herzschrittmachertherapie Elektrophysiologie, 29, 214, 10.1007/s00399-018-0565-z Jung, 2018, [Fitness to drive with cardiovascular diseases: current guidelines of the German Federal Highway Research Institute], Herz, 43, 367, 10.1007/s00059-018-4703-5 al. VJe. New standards for driving and cardiovascular diseases. Report of the Expert Group on Driving and Cardiovascular Disease 2013. Available from: https://ec.europa.eu/transport/road_safety/sites/roadsafety/files/pdf/behavior/driving_and_cardiovasc:ular_disease_final.pdf. Brignole, 2018, Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope, Eur Heart J, 39, e43, 10.1093/eurheartj/ehy071